Bio-Techne Corp

Historical 13F Holders

Symbol
TECH
CUSIP
09073M104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 09073M104 since 12/18/2024, largest first.

Filer % of Class Filed
FMR LLC 13G/A
8.1% 8/6/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 7.4% 4/29/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 7.0% 7/16/2025
Event 6/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Price T Rowe Associates Inc /MD/ 13G/A 2.2% 11/14/2025
Event 9/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 42 767 k $55.2 M
2026 Q2 622 188 M $12.5 B
2026 Q1 610 177 M $9.29 B
2025 Q4 619 172 M $10.1 B
2025 Q3 605 160 M $8.88 B
2025 Q2 576 159 M $8.20 B
2025 Q1 593 163 M $9.55 B
2024 Q4 597 162 M $11.7 B
2024 Q3 589 156 M $12.4 B
2024 Q2 594 162 M $11.6 B
2024 Q1 585 168 M $11.8 B
2023 Q4 558 161 M $12.4 B
2023 Q3 551 153 M $10.4 B
2023 Q2 556 152 M $12.4 B
2023 Q1 575 149 M $11.1 B
2022 Q4 568 157 M $13.1 B
2022 Q3 556 38.4 M $10.9 B
2022 Q2 568 37.5 M $13.0 B
2022 Q1 582 37.8 M $16.4 B
2021 Q4 602 37.0 M $19.1 B
2021 Q3 593 37.0 M $17.9 B
2021 Q2 538 36.6 M $16.5 B
2021 Q1 491 36.6 M $14.0 B
2020 Q4 459 36.5 M $11.6 B
2020 Q3 437 36.4 M $9.01 B
2020 Q2 409 36.5 M $9.65 B
2020 Q1 378 37.6 M $7.13 B
2019 Q4 382 36.3 M $7.97 B
2019 Q3 350 36.0 M $7.05 B
2019 Q2 387 35.9 M $7.56 B
2019 Q1 364 35.6 M $7.06 B
2018 Q4 336 36.0 M $5.22 B
2018 Q3 362 36.6 M $7.47 B
2018 Q2 352 38.4 M $5.43 B
2018 Q1 340 36.0 M $5.43 B
2017 Q4 299 36.4 M $4.72 B
2017 Q3 293 36.9 M $4.46 B
2017 Q2 279 37.3 M $4.39 B
2017 Q1 274 36.8 M $3.74 B
2016 Q4 285 36.2 M $3.72 B
2016 Q3 292 35.8 M $3.92 B
2016 Q2 288 38.2 M $4.31 B
2016 Q1 254 37.6 M $3.55 B
2015 Q4 264 37.8 M $3.41 B
2015 Q3 251 37.8 M $3.50 B
2015 Q2 243 36.7 M $3.62 B
2015 Q1 249 36.7 M $3.68 B
2014 Q4 260 36.4 M $3.36 B
2014 Q3 24 4.95 M $463 M